Mirxes
Asia, Central Region, Singapore, Singapore'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
Description
Mirxes is an RNA technology company that develops blood-based miRNA test kits for early disease detection.
Investor Profile
Mirxes has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A rounds (top funding stages).
- Majority of deals are located in Vietnam.
- Strong thematic focus on Health Care.
Stage Focus
- Series A (100%)
Country Focus
- Vietnam (100%)
'%3e%3cpath id='a' fill='%23FF0' d='M0 0v6h4' transform='rotate(18)'/%3e%3cuse xlink:href='%23a' transform='scale(-1 1)'/%3e%3c/g%3e%3cg id='c' transform='rotate(72)'%3e%3cuse xlink:href='%23b'/%3e%3cuse xlink:href='%23b' transform='rotate(72)'/%3e%3c/g%3e%3cuse xlink:href='%23c' transform='scale(-1 1)'/%3e%3c/svg%3e)
Industry Focus
- Health Care
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Mirxes frequently co-invest with?
What are some of recent deals done by Mirxes?
Find More Investors Like Mirxes
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
